HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2005-0094v1 2005-0094v2 23/9/1357    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shahdadfar, A. Articles by Brinchmann, J. E. Search for Related Content PubMed PubMed Citation Articles by Shahdadfar, A. Articles by Brinchmann, J. E.

In Vitro Expansion of Human Mesenchymal Stem Cells: Choice of Serum Is a Determinant of Cell Proliferation, Differentiation, Gene Expression, and Transcriptome Stability

^a Institute of Immunology,
^b Centre for Occupational and Environmental Medicine, and
^c Institute and Department of Pathology, Rikshospitalet University Hospital and University of Oslo, Norway

Key Words. Human mesenchymal stem cells • Autologous serum • Fetal bovine serum • Cell culture • Gene expression • In vitro differentiation • Microarray

Correspondence: J.E. Brinchmann, M.D., Ph.D., Institute of Immunology, Rikshospitalet University Hospital, 0027 Oslo, Norway. Telephone: 47-23-07-37-66; Fax: 47-23-07-38-22; e-mail: j.e.brinchmann{at}medisin.uio.no

Human bone marrow mesenchymal stem cells (hMSCs) represent an appealing source of adult stem cells for cell therapy and tissue engineering, as they are easily obtained and expanded while maintaining their multilineage differentiation potential. All current protocols for in vitro culture of hMSCs include fetal bovine serum (FBS) as nutritional supplement. FBS is an undesirable additive to cells that are expanded for therapeutic purposes in humans because the use of FBS carries the risk of transmitting viral and prion diseases and proteins that may initiate xenogeneic immune responses. In the present study, we have therefore investigated if autologous serum (AS) or allogeneic human serum (alloHS) could replace FBS for the expansion of hMSCs in vitro. We discovered that the choice of serum affected hMSCs at several different levels. First, hMSCs in AS proliferated markedly faster than hMSCs in FBS, whereas use of alloHS resulted in hMSC growth arrest and death. Second, hMSCs in FBS differentiated more rapidly toward mesenchymal lineages compared with hMSCs in AS. Interestingly, genome-wide microarray analysis identified several transcripts involved in cell cycle and differentiation that were differentially regulated between hMSCs in FBS and AS. Finally, several transcripts, including some involved in cell cycle inhibition, were upregulated in hMSCs in FBS at a late passage, whereas the hMSC transcriptome in AS was remarkably stable. Thus, hMSCs may be expanded rapidly and with stable gene expression in AS in the absence of growth factors, whereas FBS induces a more differentiated and less stable transcriptional profile.

This article has been cited by other articles:

				C. K. Rebelatto, A. M. Aguiar, M. P. Moretao, A. C. Senegaglia, P. Hansen, F. Barchiki, J. Oliveira, J. Martins, C. Kuligovski, F. Mansur, et al. Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue Experimental Biology and Medicine, July 1, 2008; 233(7): 901 - 913. [Abstract] [Full Text] [PDF]

				M. Inada, A. Follenzi, K. Cheng, M. Surana, B. Joseph, D. Benten, S. Bandi, H. Qian, and S. Gupta Phenotype reversion in fetal human liver epithelial cells identifies the role of an intermediate meso-endodermal stage before hepatic maturation J. Cell Sci., April 1, 2008; 121(7): 1002 - 1013. [Abstract] [Full Text] [PDF]

				F. Mannello and G. A. Tonti Concise Review: No Breakthroughs for Human Mesenchymal and Embryonic Stem Cell Culture: Conditioned Medium, Feeder Layer, or Feeder-Free; Medium with Fetal Calf Serum, Human Serum, or Enriched Plasma; Serum-Free, Serum Replacement Nonconditioned Medium, or Ad Hoc Formula? All That Glitters Is Not Gold! Stem Cells, July 1, 2007; 25(7): 1603 - 1609. [Abstract] [Full Text] [PDF]

				K. O. Gudmundsson, L. Thorsteinsson, O. E. Sigurjonsson, J. R. Keller, K. Olafsson, T. Egeland, S. Gudmundsson, and T. Rafnar Gene Expression Analysis of Hematopoietic Progenitor Cells Identifies Dlg7 as a Potential Stem Cell Gene Stem Cells, June 1, 2007; 25(6): 1498 - 1506. [Abstract] [Full Text] [PDF]

				A. Kocaoemer, S. Kern, H. Kluter, and K. Bieback Human AB Serum and Thrombin-Activated Platelet-Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue Stem Cells, May 1, 2007; 25(5): 1270 - 1278. [Abstract] [Full Text] [PDF]

				J. A. Jeong, K.-M. Ko, S. Bae, C.-J. Jeon, G. Young Koh, and H. Kim Genome-Wide Differential Gene Expression Profiling of Human Bone Marrow Stromal Cells Stem Cells, April 1, 2007; 25(4): 994 - 1002. [Abstract] [Full Text] [PDF]

				M. G. Berger, R. Veyrat-Masson, C. Rapatel, S. Descamps, J. Chassagne, and N. Boiret-Dupre Cell Culture Medium Composition and Translational Adult Bone Marrow-Derived Stem Cell Research Stem Cells, December 1, 2006; 24(12): 2888 - 2890. [Abstract] [Full Text] [PDF]

				C. A. Gregory, E. Reyes, M. J. Whitney, and J. L. Spees Enhanced Engraftment of Mesenchymal Stem Cells in a Cutaneous Wound Model by Culture in Allogenic Species-Specific Serum and Administration in Fibrin Constructs Stem Cells, October 1, 2006; 24(10): 2232 - 2243. [Abstract] [Full Text] [PDF]

				P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail Cell Culture Medium Composition and Translational Adult Bone Marrow-Derived Stem Cell Research Stem Cells, May 1, 2006; 24(5): 1409 - 1410. [Abstract] [Full Text] [PDF]